Episurf Medical
0,71 SEK +0,42%1 investor følger denne virksomhed
Episurf Medical is a medical technology company. The company conducts research and development of products used for the treatment of cartilage damage. Episurf's primary focus is on the recovery of knee joints, but the company's implants can also be applied to other joints. Episurf Medical is in the preclinical verification phase and is headquartered in Stockholm.
Omsætning
10,3 mio.
EBIT %
-938,83 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
EPIS B
Daglig lav / høj pris
0,692 / 0,736
SEK
Markedsværdi
189,62 mio. SEK
Aktieomsætning
57,34 t SEK
Volumen
79 t
Seneste videoer
Finanskalender
Delårsrapport
24.04.2024
Delårsrapport
12.07.2024
Delårsrapport
25.10.2024
Årsrapport
07.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Health Runner | 13,0 % | 13,0 % |
Fjärde AP-Fonden | 4,7 % | 4,7 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Episurf Medical AB's 2023 annual report is now available
Episurf Medical to present at Life Sciencedagen on March 6, 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools